BREAKING NEWS: Plus Therapeutics has been selected for funding by the Department of Defense (DoD) office of the Congressionally Directed Medical Research Programs (CDMRP). The award is expected to commence in Q3 2024 and will support the planned expansion of the Company’s clinical trial for pediatric brain cancer. Full Press Release: https://bit.ly/PSTV_PR #braincancer #pediatriconcology #clinicaltrials
Recent Posts
- ReSPECT Team Supports Cancer Research at the Winship 5K During Breast Cancer Awareness Month
- ReSPECT-LM Receives Additional $1.9 Million Advance Payment From CPRIT
- September Is Childhood Cancer Awareness Month
- Targeted Radiotherapies and Brain Tumor Treatment Challenges on The Bio Report Podcast
- Plus Therapeutics CEO Highlights the Role of Precision Medicine in Cancer Treatment
Recent Comments